Science that moves lives forward

Science that moves lives forward

We bridge the gap between bold medical ideas and real-world impact, advancing clinical research with precision and purpose.

At BCCC we partner with industry leaders, startups, and researchers to transform bold ideas into reliable clinical evidence – through hospital-backed trials, scientific rigor, and regulatory expertise that accelerate validation.

Clinical trials and in vitro diagnostics

We support the full journey of bringing new medicines, medical devices, and in-vitro diagnostics to market—combining practical experience with regulatory know-how to streamline each step from development to approval. BCCC also joins you to perform post-authorization and biomedical studies, among others.

Post-authorization and biomedical studies

Integrated services that drive research forward

We understand the pace and constraints of research-driven teams. Our flexible, responsive approach is built to support startups, biotech, medtech, and academic innovators from the ground up.

Why choose BCCC

Your innovation deserves a partner who understands the science and the path to approval.

A full-service CRO with deep expertise in clinical trials, regulatory strategy, and statistical consulting.
We combine agility and local insight with EU and US regulatory compliance to deliver reliable, accelerated results.
Our flexible collaboration model adapts to the needs of academic researchers, startups, and growing companies.

Partners and collaborators

News

Stay up to date with the latest news, research, and perspectives shaping clinical development and regulatory science.

BCCC Imaging Core Lab Contributes to Landmark Stroke Trial Published in JAMA 

The CHOICE-2 randomized clinical trial, coordinated by Hospital Clínic Barcelona and IDIBAPS, has been published in JAMA (Journal of American Medical Association). The study demonstrates that administering intra-arterial alteplase immediately after mechanical thrombectomy significantly improves functional outcomes in severe ischemic stroke. The centralized analysis of brain imaging data across the 14-site Spanish trial was conducted by the BCCC Imaging Core Lab.  Key Results  Among the 440 patients enrolled,… Read more »

Read more

Barcelona Clinical Coordinating Center announces completion of patient recruitment in the ANGIODAPT-01 Trial

Barcelona Clinical Coordinating Center (BCCC), the lead non-profit contract research organization (CRO) coordinating patient recruitment and clinical operations, announces the completion of patient enrollment in the ANGIODAPT-01 trial, a randomized controlled study evaluating an abbreviated dual antiplatelet therapy (DAPT) regimen following drug-eluting stent implantation. The trial has been sponsored by iVascular, a company developing innovative… Read more »

Read more

Barcelona Clinical Coordinating Center announces completion of patient recruitment in the OPAL Study

Barcelona Clinical Coordinating Center (BCCC), the non-profit contract research organization responsible for clinical coordination and patient recruitment, announces the completion of enrollment in the OPAL study, a first-in-human and pivotal clinical study evaluating the novel embolic liquid system Amber, sponsored by iVascular, a company developing innovative advanced medical devices and therapies for the treatment of… Read more »

Read more

The future of health is built by those bold enough to test it. We're here to help you prove it